BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3127921)

  • 1. Plasma determination of plasminogen activator inhibitor 1 antigen must be performed in blood collected on antiplatelet/anticoagulant mixture.
    Juhan-Vague I; Alessi MC; Fossat C; Declerck PJ; Kruithof EK
    Thromb Haemost; 1987 Dec; 58(4):1096. PubMed ID: 3127921
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of various anticoagulant/antiplatelet mixtures on determination of plasminogen activator inhibitor, platelet proteins and hemostasis parameters.
    Eriksson E; Tengborn L; Risberg B
    Thromb Haemost; 1989 Jun; 61(3):511-6. PubMed ID: 2529663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
    Sprengers ED; Akkerman JW; Jansen BG
    Thromb Haemost; 1986 Jun; 55(3):325-9. PubMed ID: 3092389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis.
    Paramo JA; de Boer A; Colucci M; Jonker JJ; Collen D
    Thromb Haemost; 1985 Oct; 54(3):725. PubMed ID: 3937271
    [No Abstract]   [Full Text] [Related]  

  • 5. Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation.
    Virji MA; Aggarwal S; Kang Y
    Transplant Proc; 1989 Jun; 21(3):3540-1. PubMed ID: 2500760
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
    Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
    Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in plasma tissue plasminogen activator and plasminogen activator inhibitor in acute myocardial infarction and its clinical significance].
    Jia HY; Chen HZ; Pu SY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Aug; 16(4):214-6, 254. PubMed ID: 3147887
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of the antiactivator activity in human and animal blood plasma using tissue plasminogen activator].
    Andreenko GV; Shimonaeva EE
    Vopr Med Khim; 1983; 29(5):112-4. PubMed ID: 6417906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA; Fernández Diaz FJ; Rocha E
    Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C; Jie AF; Rijken DC; Verheijen JH
    Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinolytic therapy--plasminogen activator inhibitors].
    Hönigl K; Pilger E; Stark G; Bertuch H
    Vasa Suppl; 1988; 26():103-6. PubMed ID: 3144048
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for a discrete binding protein of plasminogen activator inhibitor in plasma.
    Wiman B; Lindahl T; Almqvist A
    Thromb Haemost; 1988 Jun; 59(3):392-5. PubMed ID: 3142076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator inhibitor in human plasma: development of a functional assay system and demonstration of a correlating Mr = 50,000 antiactivator.
    Korninger C; Wagner O; Binder BR
    J Lab Clin Med; 1985 Jun; 105(6):718-24. PubMed ID: 3923146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy.
    Booth NA; Reith A; Bennett B
    Thromb Haemost; 1988 Feb; 59(1):77-9. PubMed ID: 3129811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancer.
    Koelbl H; Kirchheimer JC; Tatra G; Christ G; Binder BR
    Obstet Gynecol; 1988 Aug; 72(2):252-6. PubMed ID: 3134631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.
    Verheijen JH; Chang GT; Kluft C
    Thromb Haemost; 1984 Jul; 51(3):392-5. PubMed ID: 6437006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
    Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Verheijen JH; Rijken DC; Chang GT; Preston FE; Kluft C
    Thromb Haemost; 1984 Jul; 51(3):396-7. PubMed ID: 6437007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered fibrinolysis in DVT: influence of site of sampling.
    Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M
    Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.